AstraZeneca and University of Oxford coronavirus vaccine approved in India

The world’s second most populous country has approved two coronavirus vaccines, one developed by AZD1222 AstraZeneca (Nasdaq: AZN) In collaboration with Oxford University. On Sunday, the Central Drugs Standards Control Organization (CDSCO) approved emergency use of the vaccine covacin, developed by AZD 1222 (known as Covishield in India) and the Indian company Bharat Biotech.

This is the second major regulatory authorization for AZD1222 in a week’s time. Last Wednesday, the UK healthcare regulator gave it equal approval for emergency use.

Gloved hand filling syringe from vial.

Image Source: Getty Images.

AstraZeneca / Ox Xford will be able to quickly arrange their vaccine in India. The vaccine is being developed by the Serum Institute, the world’s largest vaccine producer. According to the organization, it can produce more than 50 million doses per month.

Like other coronavirus vaccines recently approved in major markets, AZD1222 is offered in two doses. These vary anywhere except four to 12 weeks.

It has a significant advantage over its competitors, however, it can be stored at the same temperature as it is found in a normal home refrigerator. Pfizer And BiotechNo. The BNT 162B2 needs to be stored in very cold climates, and ModernThe mRNA-1273 also has significant low-temperature storage requirements.

The characteristic of this refrigerator of AZD 1222 is ideal for India, parts of which can withstand triple-degree Fahrenheit in summer.

Neither AstraZeneca nor the university has yet officially commented on the approval in India. The BBC quoted Prime Minister Narendra Modi as calling it a “turning point” in his fight against the coronavirus.